| Circulating mitochondrial DNA in patients in the ICU as a marker of mortality: derivation and validation K Nakahira, SY Kyung, AJ Rogers, L Gazourian, S Youn, AF Massaro, ... PLoS medicine 10 (12), e1001577, 2013 | 437 | 2013 |
| Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials C Baigent, JR Emberson, R Haynes, WG Herrington, P Judge, ... The Lancet 400 (10365), 1788-1801, 2022 | 247 | 2022 |
| Primary outcomes of the Monitoring in Dialysis Study indicate that clinically significant arrhythmias are common in hemodialysis patients and related to dialytic cycle P Roy-Chaudhury, JA Tumlin, BA Koplan, AI Costea, V Kher, ... Kidney international 93 (4), 941-951, 2018 | 175 | 2018 |
| Mechanisms, clinical implications, and treatment of intradialytic hypotension PB Reeves, FR Mc Causland Clinical journal of the American Society of Nephrology 13 (8), 1297-1303, 2018 | 166 | 2018 |
| Autogenous versus prosthetic vascular access for hemodialysis: a systematic review and meta-analysis MH Murad, MB Elamin, AN Sidawy, G Malaga, AZ Rizvi, DN Flynn, ... Journal of vascular surgery 48 (5), S34-S47, 2008 | 151 | 2008 |
| Increased dietary sodium is independently associated with greater mortality among prevalent hemodialysis patients FR Mc Causland, SS Waikar, SM Brunelli Kidney international 82 (2), 204-211, 2012 | 138 | 2012 |
| Dialysate sodium, serum sodium and mortality in maintenance hemodialysis FR Mc Causland, SM Brunelli, SS Waikar Nephrology Dialysis Transplantation 27 (4), 1613-1618, 2012 | 111 | 2012 |
| Angiotensin-neprilysin inhibition and renal outcomes in heart failure with preserved ejection fraction FR Mc Causland, MP Lefkowitz, B Claggett, NS Anavekar, M Senni, ... Circulation 142 (13), 1236-1245, 2020 | 106 | 2020 |
| Surveillance of arteriovenous hemodialysis access: a systematic review and meta-analysis ET Casey, MH Murad, AZ Rizvi, AN Sidawy, MM McGrath, MB Elamin, ... Journal of vascular surgery 48 (5), S48-S54, 2008 | 69 | 2008 |
| Estimated glomerular filtration rate and urine biomarkers in patients with single-ventricle Fontan circulation AR Opotowsky, FR Baraona, FR Mc Causland, B Loukas, E Landzberg, ... Heart 103 (6), 434-442, 2017 | 64 | 2017 |
| Dialysis dose and intradialytic hypotension: results from the HEMO study FR Mc Causland, SM Brunelli, SS Waikar American journal of nephrology 38 (5), 388-396, 2013 | 62 | 2013 |
| Iron, hepcidin, and death in human AKI DE Leaf, M Rajapurkar, SS Lele, B Mukhopadhyay, EAS Boerger, ... Journal of the American Society of Nephrology 30 (3), 493-504, 2019 | 57 | 2019 |
| Fibroblast growth factor 23 associates with death in critically ill patients DE Leaf, ED Siew, MF Eisenga, K Singh, FR Mc Causland, A Srivastava, ... Clinical Journal of the American Society of Nephrology 13 (4), 531-541, 2018 | 54 | 2018 |
| Dapagliflozin and kidney outcomes in patients with heart failure with mildly reduced or preserved ejection fraction: a prespecified analysis of the DELIVER randomized clinical … FR Mc Causland, BL Claggett, M Vaduganathan, AS Desai, P Jhund, ... JAMA cardiology 8 (1), 56-65, 2023 | 53 | 2023 |
| Association of predialysis calculated plasma osmolarity with intradialytic blood pressure decline FR Mc Causland, SS Waikar American Journal of Kidney Diseases 66 (3), 499-506, 2015 | 53 | 2015 |
| Association of serum sodium with morbidity and mortality in hospitalized patients undergoing major orthopedic surgery FR Mc Causland, J Wright, SS Waikar Journal of hospital medicine 9 (5), 297-302, 2014 | 50 | 2014 |
| Dialysate sodium: rationale for evolution over time JE Flythe, FR Mc Causland Seminars in dialysis 30 (2), 99-111, 2017 | 49 | 2017 |
| Serum uric acid, influence of sacubitril–valsartan, and cardiovascular outcomes in heart failure with preserved ejection fraction: PARAGON‐HF S Selvaraj, BL Claggett, MA Pfeffer, AS Desai, FR Mc Causland, ... European Journal of Heart Failure 22 (11), 2093-2101, 2020 | 44 | 2020 |
| Excess mortality in solid organ transplant recipients hospitalized with COVID‐19: A large‐scale comparison of SOT recipients hospitalized with or without COVID‐19 KS Jering, MM McGrath, FR Mc Causland, B Claggett, JW Cunningham, ... Clinical Transplantation 36 (1), e14492, 2022 | 40 | 2022 |
| C-reactive protein and risk of ESRD: results from the trial to reduce cardiovascular events with aranesp therapy (TREAT) FR Mc Causland, B Claggett, EA Burdmann, KU Eckardt, R Kewalramani, ... American Journal of Kidney Diseases 68 (6), 873-881, 2016 | 39 | 2016 |
